These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2908174)

  • 1. Calcium dependent reversible inactivation of erythrocyte transglutaminase by acrylamide.
    Bergamini CM; Signorini M
    Biochem Int; 1988 Nov; 17(5):855-62. PubMed ID: 2908174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active site labeling of erythrocyte transglutaminase by o-phthalaldehyde.
    Matteucci G; Lanzara V; Ferrari C; Hanau S; Bergamini CM
    Biol Chem; 1998 Jul; 379(7):921-4. PubMed ID: 9705157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of erythrocyte transglutaminase by GTP.
    Bergamini CM; Signorini M; Poltronieri L
    Biochim Biophys Acta; 1987 Nov; 916(1):149-51. PubMed ID: 2889472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of activity and quenching of intrinsic fluorescence of transglutaminase by acrylamide are independent events.
    Signorini M; Dallocchio F; Bergamini CM
    Biochim Biophys Acta; 1988 Nov; 957(1):168-71. PubMed ID: 2902881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
    Case A; Stein RL
    Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of erythrocyte transglutaminase with calcium ions.
    Signorini M; Chiozzi P; Bergamini CM
    Biochem Int; 1989 Dec; 19(6):1205-12. PubMed ID: 2576856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of placental factor XIIIa by acrylamide.
    Signorini M; Mariotti E; Bergamini CM
    Biol Chem Hoppe Seyler; 1992 Jan; 373(1):21-5. PubMed ID: 1346962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GTP modulates calcium binding and cation-induced conformational changes in erythrocyte transglutaminase.
    Bergamini CM
    FEBS Lett; 1988 Nov; 239(2):255-8. PubMed ID: 2903073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on tissue transglutaminases: interaction of erythrocyte type-2 transglutaminase with GTP.
    Bergamini CM; Signorini M
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):37-9. PubMed ID: 8097088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of transglutaminase in mu-calpain null erythrocytes.
    O'Neill GM; Prasanna Murthy SN; Lorand L; Khanna R; Liu SC; Hanspal M; Hanada T; Chishti AH
    Biochem Biophys Res Commun; 2003 Jul; 307(2):327-31. PubMed ID: 12859959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GTP is required to stabilize and display transamidation activity of transglutaminase 2.
    Jeon JH; Cho SY; Kim CW; Shin DM; Kweon JC; Choi KH; Park SC; Kim IG
    Biochem Biophys Res Commun; 2002 Jun; 294(4):818-22. PubMed ID: 12061780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging structural understanding of transglutaminase 3.
    Ahvazi B; Boeshans KM; Rastinejad F
    J Struct Biol; 2004 Aug; 147(2):200-7. PubMed ID: 15193648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific and reversible inactivation of Phycomyces blakesleeanus isocitrate lyase by ascorbate-iron: role of two redox-active cysteines.
    Rúa J; Soler J; Busto F; de Arriaga D
    Fungal Genet Biol; 2002 Apr; 35(3):223-34. PubMed ID: 11929212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II.
    Feng JF; Readon M; Yadav SP; Im MJ
    Biochemistry; 1999 Aug; 38(33):10743-9. PubMed ID: 10451369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed mutation in conserved anionic regions of guinea pig liver transglutaminase.
    Ikura K; Yu C; Nagao M; Sasaki R; Furuyoshi S; Kawabata N
    Arch Biochem Biophys; 1995 Apr; 318(2):307-13. PubMed ID: 7733658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation.
    Freund KF; Doshi KP; Gaul SL; Claremon DA; Remy DC; Baldwin JJ; Pitzenberger SM; Stern AM
    Biochemistry; 1994 Aug; 33(33):10109-19. PubMed ID: 7914744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+-dependent neutral proteinase from human erythrocytes: activation by Ca2+ ions and substrate and regulation by the endogenous inhibitor.
    Melloni E; Salamino F; Sparatore B; Michetti M; Pontremoli S
    Biochem Int; 1984 Apr; 8(4):477-89. PubMed ID: 6089826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
    Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM
    Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GTP-dependent conformational changes associated with the functional switch between Galpha and cross-linking activities in brain-derived tissue transglutaminase.
    Monsonego A; Friedmann I; Shani Y; Eisenstein M; Schwartz M
    J Mol Biol; 1998 Oct; 282(4):713-20. PubMed ID: 9743620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a mechanism-based assay for tissue transglutaminase--results of a high-throughput screen and discovery of inhibitors.
    Case A; Ni J; Yeh LA; Stein RL
    Anal Biochem; 2005 Mar; 338(2):237-44. PubMed ID: 15745743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.